順絡電子(002138.SZ):公司產能利用率整體水平持續提升
格隆匯10月26日丨順絡電子(002138.SZ)在投資者互動平台表示,今年以來,在國內經濟弱復甦的宏觀背景下,公司下游市場景氣度開始逐漸復甦,消費及手機市場的產品,產能利用率在緩步回升,受益於前期深耕配套的大客户市場增量釋放,新產品合作不斷推進,新產品的規模化銷售有效拉動了總銷售額的提升;提前佈局的部分新產品如LTCC器件、一體成型電感等在諸多不利的外部環境影響下,仍實現了穩定、快速的增長。受益於大客户的市場增量以及新產品的繼續放量,疊加各個應用領域市場逐步回暖,公司產能利用率整體水平將持續提升,進一步帶動營收和利潤的增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.